Using text messaging to prevent HIV in young adults in Uganda

In This toGether: Testing a population-based text messaging-based HIV prevention program for young adults across Uganda

['FUNDING_R01'] · CENTER FOR INNOVATIVE PUBLIC HEALTH RESEARCH · NIH-11114048

This study is testing a text messaging program called In This toGether (ITG) to help young adults in Uganda, ages 18-22, learn about HIV prevention and encourage safer sexual behaviors and more HIV testing.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorCENTER FOR INNOVATIVE PUBLIC HEALTH RESEARCH (nih funded)
Locations1 site (SAN CLEMENTE, UNITED STATES)
Trial IDNIH-11114048 on ClinicalTrials.gov

What this research studies

This research aims to enhance HIV prevention among young adults aged 18-22 in Uganda through a text messaging program called In This toGether (ITG). The program delivers tailored HIV prevention information and resources directly to participants' mobile phones, making it accessible and engaging. By conducting a randomized controlled trial with 750 participants, the study will evaluate the effectiveness of ITG in promoting safer sexual behaviors and increasing HIV testing rates. The intervention will also be translated into three additional languages to reach a broader audience.

Who could benefit from this research

Good fit: Ideal candidates for this research are young adults aged 18-22 living in Uganda who are interested in improving their sexual health and HIV prevention knowledge.

Not a fit: Patients outside the age range of 18-22 or those not residing in Uganda may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly reduce HIV transmission rates among young adults in Uganda.

How similar studies have performed: Previous pilot studies have shown promising results for similar text messaging interventions in improving HIV prevention behaviors.

Where this research is happening

SAN CLEMENTE, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.